Change in cardio-protective medication and health-related quality of life after diagnosis of screen-detected diabetes: Results from the ADDITION-Cambridge cohort. Issue 1 (July 2015)

• Record Type: Journal Article
• Authors: Black, J.A.; Long, G.H.; Sharp, S.J.; Kuznetsov, L.; Boothby, C.E.; Griffin, S.J.; Simmons, R.K.
• Is Part Of: Diabetes research and clinical practice. Volume 109:Issue 1(2015)
• Page Start: 170
• Page End: 177
• Publication Date: 2015-07
• Subjects: Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2015.04.013
• Languages: English
• ISSNs: 0168-8227

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">We examined individuals with screen-detected diabetes over five years.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Two cardio-protective agents were prescribed at diagnosis, 3 at one year and 4 at five years.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Increases in cardio-protective medication did not impact negatively on HRQoL.</p> </list-item> </list> </p> </sec> </abstract>